A reduced graphene oxide scaffold engineered to deliver medical-grade conductive and antimicrobial performance at roughly a third of the silver a conventional fibre would need — competing on capability, at a competitive price.
To reach full medical-grade conductivity with silver alone, our analysis indicates a conventional fibre would need to carry on the order of 30%+ silver by weight — impractical and uneconomic at scale. Existing antimicrobial silver textiles run far lower and are not engineered for this level of performance. Galvanex is designed to reach the same performance target at roughly 10 wt% silver, because its 1.5 wt% rGO scaffold carries the conductive network that bulk silver would otherwise have to provide. The advantage is structural — a property of the architecture, not the silver price.
At nanoscale, what appears to be fabric reveals a precisely engineered composite — a bamboo-derived cellulose non-woven substrate enveloped in a hexagonal reduced graphene oxide lattice, with silver nanoparticles anchored at each carboxylate coordination site through proprietary molecular sequestration.
A bamboo-derived cellulose non-woven substrate is enveloped in a single-atom-thick reduced graphene oxide mesh arranged in the honeycomb geometry that gives graphene its extraordinary conductivity and tensile strength. The lattice acts as both structural scaffold and signal conduit.
Silver nanoparticles (AgNP) are anchored at each carboxylate coordination site through a proprietary nano-anchoring process. Differential surface charges (⊕/⊖) drive and maintain molecular sequestration — locking particles without adhesives or mechanical fixings.
The rGO scaffold is a universal anchor for any cation system — Ag, Zn, Cu, Ga, Mn, or Au. Each Galvanex variant shares the same lattice geometry, differing only in the ionic species sequestered at the carboxylate coordination sites.
The rGO functionalisation process integrates into standard wet-processing textile infrastructure. No specialist capital equipment required. The Galvanex variant is selected at the AgNP sequestration stage — one base process, six product outputs.
Single-atom-thick honeycomb mesh of reduced graphene oxide envelopes the fibre core — simultaneously a structural scaffold, conductivity highway, and molecular anchor framework.
Silver nanoparticle clusters at lattice junctions adopt a dendritic snowflake geometry — maximising active surface area for antimicrobial release while maintaining molecular sequestration at carboxylate coordination sites.
Carboxylate functional groups provide the coordination bridge between the rGO surface and AgNP clusters, enabling pH-responsive charge switching and irreversible particle anchoring.
At the outer membrane boundary, a pH-sensitive ion gate governs silver ion egress. Above pH 7.4 (healing wound) the gate opens; below 7.4 (infection present) the gate activates full antimicrobial release.
The rGO hexagonal lattice is a universal anchor for any cation system. Six Galvanex variants address clinical, mass-market, and research pipeline applications from the same manufacturing platform — with no change to the base textile substrate.
The foundational variant. Silver nanoparticles at snowflake geometry for maximum surface area. Broad-spectrum antimicrobial, galvanic self-repair capability, 34-cycle wash durability target.
Silver and zinc co-anchored at the rGO lattice. Synergistic antimicrobial spectrum — silver for bacterial membrane disruption, zinc for biofilm inhibition and wound-healing signalling.
Copper nanoparticles on the rGO scaffold. Antimicrobial at a fraction of silver cost — designed for pharmacy OTC, sports, and consumer wound care where clinical-grade pricing is prohibitive.
Gallium disrupts iron metabolism in bacteria — effective against antibiotic-resistant biofilm communities including Pseudomonas aeruginosa. Research-stage clinical application for chronic wound management.
Manganese is a cofactor in collagen synthesis and antioxidant defence. Textile-delivered Mn²⁺ at wound bed — a novel approach to accelerating dermal regeneration in post-surgical and diabetic wound contexts.
Gold nanoparticles for anti-inflammatory action and electrochemical sensing enhancement. The Au/rGO interface offers exceptional signal amplification — the sensing variant of the platform for continuous biomarker monitoring.
Galvanex is designed to be produced on existing technical-textile manufacturing lines — no new capital equipment and no specialist facility. The fabrication process itself is proprietary and is transferred to manufacturing partners under licence, not published here.
All manufacturing figures are engineering design targets, pending pilot-production validation before commercial commitment.
The Galvanex textile is the material substrate beneath every SOVREN clinical and military product. It is also available for OEM licensing — the rGO chemistry and manufacturing process, licensed royalty-basis to established technical textile manufacturers.
The Galvanex Galvanex Ag textile is the active layer in the Active Shield wound dressing — providing pH-gated antimicrobial release, real-time impedance sensing, and the 330 Ohm Sepsis Gate threshold.
Combat-grade antimicrobial, ESD-protective hosiery built on the Galvanex Ag substrate. Designed for sustained forward-operating-environment wear with zero additional soldier burden or electronic signature.
The Galvanex rGO functionalisation chemistry and manufacturing process, available under royalty licence to established technical textile manufacturers — no joint venture, no capital exposure, clean IP transfer.
Six layers. One rGO architecture. Earth Tack™ ground interface to Galvanex™ helmet liner — antimicrobial governance, bio-electrical grounding, and ESD protection from plantar surface to cranium. No electronics. No battery. No additional weight or RF signature.
Layer 01 · Foundation
A low-profile conductive interface device integrated into the heel zone of the boot sole. Tungsten carbide tip, vacuum-brazed to a silver-plated 316 stainless steel plunger, loaded by a beryllium-copper spring inside a 316 stainless threaded sleeve. Target impedance: below 1 Ohm at heel-strike.
Layer 02 · Plantar Governance
Galvanex™ Ag — 1.5 wt% rGO scaffold with 10 wt% silver nanoparticles — deployed across the full plantar surface from heel to toe. pH-gated ion release eliminates the biological conditions that cause trench rot before the first blister forms.
Layer 03 · Galvanic Bridge
The Galvanex™ panel covers both the gusset liner and the brief body — extending the conductive scaffold from plantar to core. The colorimetric BTB/PR indicator sits on the gusset exterior: Green/Amber/Red readable without removing clothing. Bridge resistance at nominal perspiration levels: approximately 0.25 Ohm. Well within the 10 Ohm total system budget.
Layer 04 · Wound Intelligence
The same Galvanex™ rGO scaffold — now as the active wound dressing. pH-gated antimicrobial release, real-time resistance sensing via the Silver Wand, and a colorimetric traffic-light readable without any instrument at the point of injury. Three-second wound status in forward operating environments.
Layer 05 · Somatic Data Bus
The conductive scaffold extends from plantar surface to torso in the base layer shirt — completing the Somatic Data Bus. The total system impedance budget is below 10 Ohm. The soldier's perspiration is the conductor. The rGO lattice is the highway.
Layer 06 · Cranial Governance
The final node of the Somatic Data Bus. The Galvanex™ helmet liner closes the circuit — earth to cranium — in a single, unbroken conductive scaffold. Antimicrobial governance, ESD protection for head-worn electronics, and bio-electrical continuity from ground to head.
Every layer. One rGO scaffold. Total system impedance below 10 Ohm. No electronics. No battery. No additional weight or RF signature.
All Galvanex™, Active Shield™, and Earth Tack™ performance specifications are materials science predictions based on published literature and patent specifications. Independent institutional validation is pending at UniSQ Centre for Future Materials, Toowoomba. All patent applications are Australian provisional filings — not yet examined or granted. Freedom-to-operate assessments are AI-assisted and preliminary — formal legal opinion recommended before commercial launch. Performance claims, conductivity thresholds, wash-cycle targets, and impedance figures are engineering predictions requiring pilot validation before commercial commitment. Galvanex™, Active Shield™, Earth Tack™, Ion Storm, Silver Wand™, SOVREN™, and Somatic Data Bus™ are trademarks of Adam W. Bell · ABN 67 996 925 236. May 2026.
All applications are Australian provisional filings — not yet examined or granted. Priority dates are real and legally significant. Formal legal opinion recommended before commercial launch.
Percolation threshold, galvanic self-repair mechanism, AgNP snowflake geometry anchoring at carboxylate coordination sites. The foundational Galvanex claim. Filed March 2026.
Owned prior art filing establishing the legacy system cost and performance baseline. Creates the legal frame for the cost arbitrage comparison. Filed March 2026.
Percolation phase conductivity claim across noble metal loading on non-woven substrates. Underpins the Galvanex variant architecture. Filed March 2026.
Interchangeable frame and active insert system enabling sequential therapeutic deployment from a single garment platform. Enables multi-variant product family from one SKU. Filed May 2026.
pH-gated ion release, 330 Ohm sepsis gate, N_max = 34 cycles, Rinse-to-Restore protocol. The Active Shield clinical claim. Filed March 2026.
Military sock foundation patent. Galvanex textile as the conductive layer in a modular antimicrobial/ESD-protective hosiery system. Filed February 2026.
All Galvanex™ and SOVREN Advanced Textiles patent applications are Australian provisional filings — not yet examined or granted. All performance specifications, cost figures, wash-cycle targets, conductivity thresholds, and manufacturing timelines are materials science predictions based on published literature and patent specifications. Independent institutional validation is pending at UniSQ Centre for Future Materials, Toowoomba. Freedom-to-operate assessments are AI-assisted and preliminary — formal legal opinion recommended before commercial launch. Galvanex™, Active Shield™, Ion Storm, Silver Wand™, and SOVREN™ are trademarks of Adam W. Bell · ABN 67 996 925 236. May 2026.